1789c. Interactive Panelist
Session: Interactive Session: Challenging Cases in ID
Saturday, October 5, 2013: 3:20 PM
Room: The Moscone Center: Esplanade Ballroom 301-310
Stephen B. Calderwood, MD, FIDSA, Diviaion Of Infectious Diseases, Massachusetts General Hospital, Boston, MA

Stephen B. Calderwood, M.D.
Chief, Division of Infectious Diseases, Massachusetts General Hospital
Morton N. Swartz MD Academy Professor of Medicine (Microbiology and Immunobiology), Harvard Medical School
Dr. Calderwood received his Bachelor of Science degree from Harvard University (1971) and his M. D. degree from Harvard Medical School (1975). He did medical residency training at the Massachusetts General Hospital (MGH), as well as Clinical and Research Fellowship in Infectious Diseases and Chief Residency at MGH, before joining the faculty there and at Harvard in 1982. He did additional laboratory research training with Dr John Mekalanos at Harvard Medical School (HMS), before establishing his own research laboratory at the MGH in 1988. Dr. Calderwood’s research interests focus on microbial pathogenesis, microbial-host interactions, regulation of gene expression in the human host, and vaccine development. He is the Principal Investigator of an International Collaborations in Infectious Disease Research grant focused on cholera with the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh. Dr. Calderwood is a Scholar in the Academy and a member of the Curriculum Cabinet at HMS, and directs the Principal Clinical Experience for third year HMS students at MGH. Dr. Calderwood is a Fellow of the American College of Physicians, the Infectious Diseases Society of America, the American Academy of Microbiology, and the American Association for the Advancement of Science. He has published over 200 journal articles, reviews and book chapters on a variety of topics related to infectious disease and microbiology. His clinical interests are in antimicrobial agents, gastrointestinal infections, endocarditis, central nervous system infections, and biodefense.

See more of: Challenging Cases in ID
See more of: Interactive Session
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.